Ming X - Search Results

1

Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells.

Xue G, Wang Z, Zheng N, Fang J, Mao C, Li X, Jin G, Ming X, Lu Y. Xue G, et al. Among authors: ming x. Nat Biomed Eng. 2021 Nov;5(11):1306-1319. doi: 10.1038/s41551-021-00799-6. Epub 2021 Nov 1. Nat Biomed Eng. 2021. PMID: 34725506 Free PMC article.

2

P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors.

Mao C, Zhao Y, Li F, Li Z, Tian S, Debinski W, Ming X. Mao C, et al. Among authors: ming x. J Control Release. 2018 Sep 28;286:289-300. doi: 10.1016/j.jconrel.2018.08.005. Epub 2018 Aug 4. J Control Release. 2018. PMID: 30081143 Free PMC article.

3

P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.

Mao C , Qu P , Miley MJ , Zhao Y , Li Z , Ming X . Mao C , et al. Among authors: ming x. Biomater Sci. 2018 Oct 24;6(11):3063-3074. doi: 10.1039/c8bm00844b. Biomater Sci. 2018. PMID: 30298866 Free PMC article.

4

P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.

Mao C, Li F, Zhao Y, Debinski W, Ming X. Mao C, et al. Among authors: ming x. Theranostics. 2018 Nov 29;8(22):6274-6290. doi: 10.7150/thno.29580. eCollection 2018. Theranostics. 2018. PMID: 30613297 Free PMC article.

5

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.

Mao C, Yeh S, Fu J, Porosnicu M, Thomas A, Kucera GL, Votanopoulos KI, Tian S, Ming X. Mao C, et al. Among authors: ming x. Sci Transl Med. 2022 Jun 8;14(648):eabh1261. doi: 10.1126/scitranslmed.abh1261. Epub 2022 Jun 8. Sci Transl Med. 2022. PMID: 35675434 Free PMC article.

6

MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer.

Li F, Mao C, Yeh S, Sun Y, Xin J, Shi Q, Ming X. Li F, et al. Among authors: ming x. Int J Pharm. 2021 Jul 15;604:120760. doi: 10.1016/j.ijpharm.2021.120760. Epub 2021 May 30. Int J Pharm. 2021. PMID: 34077781

7

Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer.

Li F, Mao C, Yeh S, Xin J, Wang P, Shi Q, Ming X. Li F, et al. Among authors: ming x. Int J Pharm. 2022 Sep 25;625:122076. doi: 10.1016/j.ijpharm.2022.122076. Epub 2022 Aug 3. Int J Pharm. 2022. PMID: 35931394

8

Multiarm Nanoconjugates for Cancer Cell-Targeted Delivery of Photosensitizers.

Zhao Y, Li F, Mao C, Ming X. Zhao Y, et al. Among authors: ming x. Mol Pharm. 2018 Jul 2;15(7):2559-2569. doi: 10.1021/acs.molpharmaceut.8b00088. Epub 2018 May 30. Mol Pharm. 2018. PMID: 29764120 Free PMC article.

9

RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer.

Li F, Zhao Y, Mao C, Kong Y, Ming X. Li F, et al. Among authors: ming x. Mol Pharm. 2017 Aug 7;14(8):2793-2804. doi: 10.1021/acs.molpharmaceut.7b00321. Epub 2017 Jul 25. Mol Pharm. 2017. PMID: 28700237 Free PMC article.

10

Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe.

Wang M, Mao C, Wang H, Ling X, Wu Z, Li Z, Ming X. Wang M, et al. Among authors: ming x. Mol Pharm. 2017 Oct 2;14(10):3391-3398. doi: 10.1021/acs.molpharmaceut.7b00420. Epub 2017 Aug 30. Mol Pharm. 2017. PMID: 28813596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters